KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Clorox (CLX) over the last 16 years, with Q4 2025 value amounting to $55.0 million.

  • Clorox's Depreciation & Amortization (CF) rose 377.36% to $55.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $223.0 million, marking a year-over-year decrease of 44.64%. This contributed to the annual value of $219.0 million for FY2025, which is 680.85% down from last year.
  • As of Q4 2025, Clorox's Depreciation & Amortization (CF) stood at $55.0 million, which was up 377.36% from $56.0 million recorded in Q3 2025.
  • Over the past 5 years, Clorox's Depreciation & Amortization (CF) peaked at $62.0 million during Q2 2023, and registered a low of $53.0 million during Q1 2021.
  • For the 5-year period, Clorox's Depreciation & Amortization (CF) averaged around $56.6 million, with its median value being $56.5 million (2022).
  • Its Depreciation & Amortization (CF) has fluctuated over the past 5 years, first surged by 1777.78% in 2021, then plummeted by 1147.54% in 2024.
  • Clorox's Depreciation & Amortization (CF) (Quarter) stood at $55.0 million in 2021, then increased by 5.45% to $58.0 million in 2022, then decreased by 1.72% to $57.0 million in 2023, then dropped by 7.02% to $53.0 million in 2024, then grew by 3.77% to $55.0 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $55.0 million for Q4 2025, versus $56.0 million for Q3 2025 and $57.0 million for Q2 2025.